Pharmsynthez (MOEX:LIFE)
Russia flag Russia · Delayed Price · Currency is RUB
4.505
+0.415 (10.15%)
At close: Jul 8, 2022

Pharmsynthez Balance Sheet

Millions RUB. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Jun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2.061.524.989.1715.310.41
Short-Term Investments
2.592.54----
Cash & Short-Term Investments
4.664.064.989.1715.310.41
Cash Growth
1185.91%-18.50%-45.74%-40.03%46.89%-84.44%
Accounts Receivable
86.4828.8796.0172.0369.0666.02
Other Receivables
141.76145.12169.070.88.03164.1
Receivables
228.24174265.0877.5579.21288.79
Inventory
49.2562.6263.5641.9536.1969.56
Prepaid Expenses
---69.3875.5496.32
Other Current Assets
15.1321.636.160.040.040.04
Total Current Assets
297.27262.27369.79198.1206.27465.13
Property, Plant & Equipment
415.71430.94468.54344.58326.7352.12
Long-Term Investments
783.64781.5793.1433.5125.14487.73
Other Intangible Assets
211.94211.86216.21331.9337.23349.83
Long-Term Deferred Tax Assets
1,0431,0411,086366.61365.25329.17
Other Long-Term Assets
---63.2363.2368.2
Total Assets
2,7512,7272,9341,3381,4252,052

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Jun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Accounts Payable
537.28530.94442.52178.66141.29177.76
Accrued Expenses
24.4216.8115.63105.61104.1883.88
Short-Term Debt
-361.85335591.72579.81573.52
Current Portion of Long-Term Debt
352.76--103.2241.5535.85
Current Portion of Leases
0.810.939.878.69-0.95
Current Income Taxes Payable
---29.2315.5512.31
Other Current Liabilities
1.163.1543.75157.93110.95140.58
Total Current Liabilities
916.43913.67846.771,175993.331,025
Long-Term Debt
55.11--16.5586.8513.2
Long-Term Leases
0.70.9320.1525.22--
Total Liabilities
972.24914.6866.921,2171,0801,038

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Jun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Common Stock
2,2022,2022,2021,5051,5051,505
Additional Paid-In Capital
4,8534,8534,8533,5313,5313,531
Retained Earnings
-5,276-5,242-4,988-4,445-4,238-3,540
Comprehensive Income & Other
000-469.45-452.76-481.47
Total Common Equity
1,7791,8132,067121.1345.281,014
Shareholders' Equity
1,7791,8132,067121.1345.281,014
Total Liabilities & Equity
2,7512,7272,9341,3381,4252,052

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period Ending
Jun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Total Debt
409.38363.71365.02745.4708.21623.52
Net Cash (Debt)
-404.73-359.65-360.04-736.23-692.91-613.1
Net Cash Growth
------
Net Cash Per Share
-0.97-0.82-0.82-2.45-2.30-2.04
Filing Date Shares Outstanding
440.39440.39456.83301.01301.01301.01
Total Common Shares Outstanding
440.39440.39456.83301.01301.01301.01
Working Capital
-619.15-651.4-476.98-976.95-787.05-559.73
Book Value Per Share
4.044.124.520.401.153.37
Tangible Book Value
1,5671,6011,850-210.88.05664.29
Tangible Book Value Per Share
3.563.634.05-0.700.032.21
Land
181.5181.5150.73161.11159.14155.22
Buildings
160.7160.7182.39---
Machinery
320.76323.29320.59515.92523.17541
Construction In Progress
---143.66143.66143.66